Atlas Trials

The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.

Clinical trial NCT06797570 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06797570
Sponsor
St. Antonius Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Attention Deficit DisorderAttention Deficit Disorder (ADD)Attention Deficit Disorder with HyperactivityADHDADDADHD-not Other SpecifiedADHD or ADHD TraitsADHD Predominantly Hyperactivity TypeADHD Predominantly Inattentive TypeADHD with Sleep Onset InsomniaADHD, ADDADHD, Predominantly Hyperactive - Impulsive
Start date
2025-01-25
Primary completion
2027-01-06
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.